РОЗРОБКА CЕЛЕКТИВНОГО СЕРЕДОВИЩА ДЛЯ ВИДІЛЕННЯ ТОКСИН ПРОДУКУЮЧИХ ШТАМІВ C. DIFFICILE
Open Access
- 16 October 2020
- journal article
- Published by RS Global Sp. z O.O. in World Science
Abstract
Enterocolitis disorders caused by Clostridioides difficile infection still remain a serious health problem in the world. In many countries CDI is officially considered a nosocomial infection that causes considerable economic losses, including diagnostic and treatment costs. According to the existing data, C. difficile is the main agent causing antibiotic – associated diarrhea and the main etiologic factor of the pseudomembranous colitis (PMC) that often develops in case of complete destruction of the intestinal flora due to the use of antibiotics or chemotherapeutic agents. There is no official registration of CDI in Ukraine, therefore the official incidence and lethality rates are absent. At this time, the problems of development and improvement of selective nutrient mediums and quick, affordable bacteriological methods of C. difficile isolation are especially relevant.The comparative study of the efficacy of the known commercial nutrient mediums for isolation of toxin-producing strains of C. difficile was carried out and composition of a new, original selective nutrient medium was proposed. Unlike existing analogs, the proposed nutrient medium is suitable for the simultaneous isolation of the agent from the clinical material and detection of toxin-producing properties due to its high growth properties, optimal transparency and density.This publication has 13 references indexed in Scilit:
- Characteristics of Clostridium difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a tertiary teaching hospital in Chongqing, Southwest ChinaBMC Infectious Diseases, 2020
- Clostridium difficile – From Colonization to InfectionFrontiers in Microbiology, 2018
- Comparative efficacy and tolerability of probiotics for antibiotic‐associated diarrhea: Systematic review with network meta‐analysisUnited European Gastroenterology Journal, 2017
- List of new names and new combinations previously effectively, but not validly, publishedInternational Journal of Systematic and Evolutionary Microbiology, 2017
- PEDIATRIC RESEARCH AND CLINICAL CENTER FOR INFECTIOUS DISEASES, ST. PETERSBURG, RUSSIAMarine Medicine, 2017
- Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O’Toole 1935) Prévot 1938Anaerobe, 2016
- Burden ofClostridium difficileInfection in the United StatesThe New England Journal of Medicine, 2015
- Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and functionGlycobiology, 2007
- Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxinsBiochimica et Biophysica Acta (BBA) - General Subjects, 2004
- Characterization of a Cell Surface Protein of Clostridium difficile with Adhesive PropertiesInfection and Immunity, 2001